UMP Healthcare Holdings Limited provided earnings guidance for the financial year ended 30 June 2017. The board of directors of the Company announced that, based on the information currently available to the board and the preliminary review of the unaudited management accounts of the Group, the Board expects that the net profit of the company for the financial year ended 30 June 2017 will represent a significant increase of approximately 600% as compared with the net profit of HKD 6.8 million for the financial year ended 30 June 2016. Excluding the financial impact of the Proposed Disposal and the PRC Developing Business, the company's adjusted EBITDA has increased by approximately 10.5% in 2017. Such increase was due to overall improving operating performance. Based on the preliminary review of the unaudited management accounts of the Group, the Company expects to record a total revenue of approximately HKD 514 million in fiscal year 2017, representing a year on year increase of approximately 13%.